Pharmaceuticals

Generic Oncology Drugs Market to 2027 - Global Analysis and Forecasts by Molecular Type (Large Molecule, Small Molecule); Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Kidney Cancer, Cervical Cancer, Others), and Geography

  • THE3262345
  • 152 Pages
  • August 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
The global generic oncology drugs market is expected to reach US$ 36,029.60 Mn in 2027 from US$ 21,200.00 in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.

Factors such as, growing cancer prevalence across the globe, new product launches and benefits offered by generic drugs are boosting the market over the years. In addition, the growing pharmaceutical industry in developing countries are likely to have a positive impact on the growth of the market in the coming years.

Generic drugs are copies of branded drugs. Their pharmacological effects are similar to the branded counterparts. Generic drugs are cost effective as the manufacturers have not invested in the development and marketing of the new drug. When a drug patent expires, other manufacturers apply for FDA approval in order to manufacture and sell the product. Hence generic drugs are cheaper than branded drugs. The generic drug have exactly the same effects, dosage, side effects, route of administration, safety, risks, and strength as the original branded drug. Generic drugs are important in oncology as some anticancer drugs are only offered as generics. In most of the cases like, children with acute lymphoblastic leukemia or women patients with early-stage breast cancer are treated with generics. Generic drugs are extensively used in supportive care. The most significant benefit of using generic drugs is the cost, which is up to 85% less than that of a branded drugs. Thus, these benefits offered by generic drugs is likely to enhance the market growth during the forecast period.

The global generic oncology drugs market, based on the indication was segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, kidney cancer, cervical cancer, others. In 2018, the lung cancer segment held the largest share of the market, by indication. The highest share of lung cancer segment attributes to the high prevalence of patients suffering with the lung cancer that can be treated with generic oncology drugs.

Some of the major primary and secondary sources included in the report for the Generic Oncology Drugs Market are the World Health Organization, British Generics Manufacturers Association, Centers for Disease Control and Prevention, Cancer Association of South Africa, Italian Association for Cancer Research, American Cancer Society, Indian Brand Equity Foundation, and others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Generic Oncology Drugs Market – By Molecule Type

1.3.2 Global Generic Oncology Drugs Market – By Application

1.3.3 Global Generic Oncology Drugs Market – By Geography

2. Global Generic Oncology Drugs Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Generic Oncology Drugs– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa– PEST Analysis

4.2.5 South & Central America – PEST Analysis

4.3 Expert Opinions

5. Global Generic Oncology Drugs Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Growing Cancer Prevalence Across The Globe

5.1.2 New Drug Launches

5.1.3 Benefits Offered By Generic Drugs

5.2 Key Market Restraints

5.2.1 Pricing Pressure

5.3 Key Market Opportunities

5.3.1 Growing Pharmaceutical Industry in Emerging Economies

5.4 Future Trends

5.4.1 Inclination Towards Personalized Medicine

5.5 Impact Analysis

6. Generic Oncology Drugs Market – Global Analysis

6.1 Global Generic Oncology Drugs Market Revenue Forecasts And Analysis

6.2 Global Generic Oncology Drugs Market, By Geography - Forecasts And Analysis

6.3 Market Positioning of Key Players

7. Generic Oncology Drugs Market Analysis And Forecasts To 2027 – Molecule Type

7.1 Overview

7.2 Global Generic Oncology Drugs Market Share by Molecule Type 2018 & 2027 (%)

7.3 Large Molecules Market

7.3.1 Overview

7.3.2 Large Molecules Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Small Molecules Market

7.4.1 Overview

7.4.2 Small Molecules Market Revenue and Forecast to 2027 (US$ Mn)

8. Generic Oncology Drugs Market Analysis And Forecasts To 2027 – Indication

8.1 Overview

8.2 Global Generic Oncology Drugs Market Share by Indication 2018 & 2027 (%)

8.3 Lung Cancer

8.3.1 Overview

8.3.2 Lung Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.4 Stomach Cancer

8.4.1 Overview

8.4.2 Stomach Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.5 Colorectal Cancer

8.5.1 Overview

8.5.2 Colorectal Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.6 Breast Cancer

8.6.1 Overview

8.6.2 Breast Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.7 Prostate Cancer

8.7.1 Overview

8.7.2 Prostate Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.8 Liver Cancer

8.8.1 Overview

8.8.2 Liver Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.9 Kidney Cancer

8.9.1 Overview

8.9.2 Kidney Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.10 Cervical Cancer

8.10.1 Overview

8.10.2 Cervical Cancer Market Revenue and Forecast to 2027 (US$ Mn)

8.11 Others

8.11.1 Overview

8.11.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

9. Generic Oncology Drugs Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1 North America Generic Oncology Drugs Market Revenue And Forecasts To 2027

9.1.1 North America Generic Oncology Drugs market Revenue and Forecasts to 2027 (US$ Mn)

9.2 North America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.3 North America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.3.1 North America Generic Oncology Drugs Market Revenue and Forecasts to 2027, By Country (%)

9.3.2 US Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.2.1 US Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.2.2 US Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.3.2.3 US Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.3.3 Canada Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3.1 Canada Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.4 Canada Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.3.5 Canada Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.3.6 Mexico Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.1 Mexico Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7 Mexico Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.3.8 Mexico Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.4 Europe Generic Oncology Drugs Market Revenue And Forecasts To 2027

9.4.1 Europe Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Europe Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.6 Europe Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.6.1 Europe Generic Oncology Drugs Market Revenue and Forecasts to 2027, By Country (%)

9.6.2 UK Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.2.1 UK Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.3 UK Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.6.4 UK Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.6.5 Germany Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.5.1 Germany Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.6 Germany Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.6.7 Germany Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.6.8 France Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.8.1 France Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.9 France Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.6.10 France Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.6.11 Italy Generic oncology drugs market Revenue and Forecasts to 2027 (US$ Mn)

9.6.11.1 Italy Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.12 Italy Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.6.13 Italy Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

9.6.14 Spain Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.14.1 Spain Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.15 Spain Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

9.6.16 Spain Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

10. Asia Pacific Generic Oncology Drugs Market Revenue and Forecasts to 2027

10.1 Overview

10.2 Asia Pacific Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.3 Asia Pacific Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

10.4 Asia Pacific Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

10.5 Asia Pacific Generic Oncology Drugs Market Revenue and Forecasts to 2027, By Country (%)

10.6 Japan Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.1 Japan Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.2 Japan Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

10.6.3 Japan Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

10.7 China Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.7.1 China Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.7.2 South Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

10.7.3 China Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

10.8 India Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.1 India Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.2 India Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

10.8.3 India Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

10.9 Australia Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.9.1 Australia Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.9.2 Australia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

10.9.3 Australia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

10.10 South Korea Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.10.1 South Korea Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

10.10.2 South Korea Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

10.10.3 South Korea Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

11. Middle East & Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027

11.1 Overview

11.2 Middle East & Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.3 Middle East & Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

11.4 Middle East & Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

11.5 Middle East & Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027, By Country (%)

11.6 South Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.6.1 South Africa Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.6.2 South Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

11.6.3 South Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

11.7 Saudi Arabia Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.7.1 Saudi Arabia Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.7.2 Saudi Arabia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

11.7.3 Saudi Arabia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

11.8 UAE Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.8.1 UAE Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

11.8.2 UAE Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

11.8.3 UAE Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

12. South and Central America Generic Oncology Drugs Market Revenue and Forecasts to 2027

12.1 Overview

12.2 South and Central America Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

12.3 South and Central America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

12.4 South and Central America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

12.5 South and Central America Generic Oncology Drugs Market Revenue and Forecasts to 2027, By Country (%)

12.6 Brazil Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

12.6.1.1 Brazil Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

12.6.2 Brazil Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

12.6.3 Brazil Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

12.6.4 Argentina Generic Oncology Drugs Market

12.6.4.1 Argentina Generic Oncology Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

12.6.5 Argentina Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

12.6.6 Argentina Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

13. Generic Oncology Drugs Market – Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Generic Oncology Drugs Market, 2016-2019

13.3 Organic Growth Strategies

13.4 Inorganic Growth Strategies

14. Generic Oncology Drugs Market–Key Company Profiles

14.1 Dr. Reddy’s Laboratories Ltd

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Financial Overview

14.1.4 Product Portfolio

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Fresenius Kabi AG

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Financial Overview

14.2.4 Product Portfolio

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Cipla Inc.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Financial Overview

14.3.4 Product Portfolio

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Mylan N.V.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Financial Overview

14.4.4 Product Portfolio

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Zydus Cadila

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Financial Overview

14.5.4 Product portfolio

14.5.5 SWOT Analysis

14.5.6 KEY DEVELOPMENTS

14.6 Intas Pharmaceuticals

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Financial Information

14.6.4 Product Portfolio

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Aurobindo Pharma

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Financial Overview

14.7.4 Product Portfolio

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Teva Pharmaceutical Industries Ltd.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Financial Overview

14.8.4 Product Portfolio

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Sandoz International GmbH (A Division of Novartis AG)

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Financial Overview

14.9.4 Product Portfolio

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Glenmark

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Financial Overview

14.10.4 Product Portfolio

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Sun Pharmaceutical Industries Ltd.

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Financial Overview

14.11.4 Product Portfolio

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 MSN Laboratories

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Financial Overview

14.12.4 Product Portfolio

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary Of Terms

LIST OF TABLES

Table 1. North America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 2. North America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 3. US Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 4. US Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 5. Canada Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 6. Canada Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 7. Mexico Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 8. Mexico Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 9. Europe Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 10. Europe Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 11. UK Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 12. UK Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 13. Germany Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 14. Germany Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 15. France Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 16. France Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 17. Italy Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 18. Italy Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 19. Spain Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 20. Spain Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 21. Asia Pacific Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 22. Asia Pacific Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 23. Japan Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 24. Japan Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 25. China Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 26. China Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 27. India Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 28. India Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 29. Australia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 30. Australia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 31. South Korea Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 32. South Korea Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 33. Middle East & Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 34. Middle East & Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 35. South Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 36. South Africa Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 37. Saudi Arabia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 38. Saudi Arabia Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 39. UAE Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 40. UAE Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 41. South and Central America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 42. South and Central America Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 43. Brazil Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 44. Brazil Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 45. Argentina Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Molecule Type (US$ Mn)

Table 46. Argentina Generic Oncology Drugs Market Revenue And Forecasts to 2027, By Indication (US$ Mn)

Table 47. Glossary Of Terms, Generic Oncology Drugs Market

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370